Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Triple Negative Breast Neoplasms × Temozolomide × Clear all

Sponsor

Conditions

Glioblastoma 104 Brain Neoplasms 50 Gliosarcoma 48 Glioma 42 Central Nervous System Neoplasms 28 Astrocytoma 27 Melanoma 21 Oligodendroglioma 14 Neuroblastoma 10 Neoplasm Metastasis 8 Ependymoma 7 Recurrence 6 Neoplasms 6 Sarcoma, Ewing 5 Lymphoma 5 Spinal Cord Neoplasms 4 Skin Neoplasms 4 Sarcoma 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Medulloblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Somatostatinoma 3 Gastrinoma 3 Colorectal Neoplasms 3 Carcinoma, Islet Cell 3 Uveal Melanoma 2 Rhabdomyosarcoma 2 Pinealoma 2 Pancreatic Neoplasms 2

Interventions

Paclitaxel 33 pembrolizumab 30 Carboplatin 28 Cyclophosphamide 18 Albumin-Bound Paclitaxel 18 Taxes 15 130-nm albumin-bound paclitaxel 15 Doxorubicin 14 atezolizumab 13 Capecitabine 13 Cisplatin 11 Nivolumab 9 Docetaxel 8 olaparib 7 Gemcitabine 6 talazoparib 5 durvalumab 5 Everolimus 5 Biopsy 5 Bevacizumab 5 spartalizumab 4 pegfilgrastim 4 liposomal doxorubicin 4 eribulin 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 sacituzumab govitecan 3 entinostat 3 bintrafusp alfa protein, human 3 Trastuzumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡